ALKS (Alkermes Corp) Wutah bathi resik saben saham ing taun iki

Simbol resmi perusahaan Alkermes plc (ALKS)

Alkermes plc (ALKS) is scaling its neurobiology portfolio following the spin-off of its oncology division, a move corroborated by the annual EPS volatility. Patents for extended-release injections serve as a business moat, while environmental sustainability is driven by the implementation of "green chemistry." The value of -137.30 shapes the current metric, demonstrating the impact of global liquidity on earnings per share dynamics.

ALKS (Alkermes plc) riwayat Wutah bathi saben saham ing taun lumaku saka 04.07.2022 nganti 12.11.2026

Rincian analitis lan laporan data perusahaan Alkermes plc (ALKS)

- nilai saham lan prakiraan konsensus rega:
Rega bursa Alkermes PLC|ALKS - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Biji pasar Alkermes Corp|ALKS - Nilai Perusahaan
- rincian nilai buku perusahaan:
Nilai Akuntansi Saham Alkermes|ALKS - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku alkermes.com|ALKS - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Total Utang marang Modal Alkermes plc|ALKS - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas alkermes.com|ALKS - Utang perusahaan|Utang-utang marang kapitalisasi buku Alkermes Corp|ALKS - Utang jangka dawa perusahaan|Utang jangka cendhak Alkermes|Rasio jangkoan perantara alkermes.com
- indikator pendapatan resik lan kelipatan nilai:
ALKS - Bathi resik perusahaan|Bathi mangsa ngarep Alkermes plc|ALKS - Pangali P/E|Rasio prakiraan rega marang bathi Alkermes Corp|ALKS - Rasio rega marang bathi tumrap wutah|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Alkermes Corp|ALKS - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajroning taun lumaku Alkermes|ALKS - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan alkermes.com|ALKS - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Alkermes plc
Analisis dhasar perusahaan:Alkermes plc
Produk asil prodhuksi alkermes.com

Institutional capital assesses the attractiveness of Alkermes plc (ALKS) through the stability of its profit generation, which may fluctuate due to costs associated with contract research organizations (CRO). By analyzing current year-over-year EPS dynamics, investors can track the percentage change in net income per share, allowing them to determine the business model's resilience to market shocks and evaluate the asset's actual reliability.

Pesaing langsung

Kacepetan wutah bathi saben saham ing taun lumaku Avadel Pharmaceuticals PLC (AVDL)|ATAI (atai Life Sciences Corp) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki GH Research Group (GHRS)|Wutah bathi ing taun lumaku MNMD|CMPS (compasspathways.com) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku LB Pharmaceuticals LBRX|Bright Minds Bio (DRUG) - Kacepetan wutah bathi saben saham ing taun lumaku|Vanda Pharmaceuticals Inc - Wutah bathi ing taun lumaku|CYBN - Wutah bathi ing taun lumaku|Alto Neuroscience, Inc. (ANRO) - Wutah bathi saben saham ing taun lumaku|NRXP (nrxpharma.com) - Wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Cingulate Inc|Wutah bathi ing taun lumaku Silo Pharma Inc.|Wutah bathi ing taun lumaku CPHI|CMND - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Psyence Biomedical Ltd. PBM|Tambahing bathi saben saham ing taun lumaku SPRC|SEEL - Wutah bathi saben saham ing taun lumaku|Virpax Pharmaceuticals (VRPX) - Wutah bathi resik saben saham ing taun iki|KRTX: Wutah bathi ing taun lumaku